Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
9 participants
INTERVENTIONAL
2016-06-30
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Subjects will complete a total of fifteen (15) sessions which include a combination of the following; Physical Therapy Evaluation, Indego Training, Mid-Way Assessment, and Post-Assessment.
The aim of this study is to measure the impact of gait training with the Indego device on body structure, function, and participation. Additionally it will assess the perceptions of physical therapists and subjects with SCI on the effectiveness of gait training with the Indego exoskeleton in subjects with preserved limited function.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Indego® Exoskeleton; Assessing Mobility for Persons With Spinal Cord Injury (SCI).
NCT02202538
Seated Balance Using the Indego™
NCT04047992
Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2)
NCT03082898
Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Home and Community Setting (SC140121 Study 3)
NCT04149769
Self-balancing Personal Exoskeleton for SCI
NCT06777576
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SCI Patients
* 10 subjects with complete or incomplete SCI (\> 1 year post-injury) with preserved LE function will be recruited.
* No control group
Indego Powered Exoskeleton
Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Indego Powered Exoskeleton
Subjects who have Spinal Cord Injury will wear the Indego device which will include being trained and evaluated for fifteen (15) sessions.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Height 5'1" to 6'3" (Acceptable height may vary by a few inches depending on femur length)
* Weight 250 lbs or less
* Present with paraplegia resulting from a complete or incomplete (AIS A, B, C, or D) Spinal Cord Injury (\>1 year post-injury), with preserved LE function
* Uses wheelchair as primary means of mobility in the community
* Able to ambulate 14 meters with assist of 2 people and no orthostasis. Subjects may use any combination of stability aids and/or bracing.
* Medical clearance for weight bearing and locomotor training
* Bone density exams will be at the discretion of each sites' Principle Investigator
* Passive range of motion (PROM) at shoulders, trunk, hips, knees and ankles within functional limits for safe gait and use of appropriate assistive device/stability aid
* Skin intact where interfaces with the Indego device
* Modified Ashworth Scale 3 or less in bilateral LEs
* Blood pressure and heart rate within Locomotor Training Guidelines
* At rest: Systolic 150 or less Diastolic 90 or less and Heart rate 105 or less
* Exercise: Systolic 180 or less Diastolic 105 or less and Heart Rate 145 or less
* Currently participating in physical therapy for gait training
* Joint contractures of the shoulders, trunk, hips knees or ankles deemed unsafe for locomotor training by PT and or MD
* Edema that would put skin at risk for breakdown
* Modified Ashworth Spasticity of 4
* Inability to achieve adequate fit of the Indego device
* Pregnancy
* Colostomy bag
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Parker Hannifin Corporation
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St. Charles Hospital
Port Jefferson, New York, United States
TIRR Memorial Hermann
Houston, Texas, United States
Sheltering Arms
Mechanicsville, Virginia, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
15-01399
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.